Anish Bhatnagar, CEO of Soleno Therapeutics ($SLNO), sold shares on the open market 12 times over the past year, totaling $47.3 million. His most recent sale occurred on March 27, 2025. These transactions rank him 333rd among nearly 12,000 insiders by sale value, well above the average of $8.6 million across 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | A | Employee stock option (right to buy) | 131400 | $0.00 | 131,400.0000 | 54,921,916 | 9999.99% | 0.24% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | A | Common Stock | 114200 | $0.00 | 583,656.0000 | 54,921,916 | 24.33% | 0.21% |
| Dec. 15, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | F | Common Stock | 7620 | $49.95 | 569,456.0000 | 54,921,916 | 1.32% | 0.01% |
| Dec. 15, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | G | Common Stock | 100000 | $0.00 | 469,456.0000 | 54,921,916 | 17.56% | 0.18% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Common Stock | 26606 | $24.00 | 603,682.0000 | 40,175,926 | 4.61% | 0.07% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Common Stock | 16666 | $25.05 | 620,348.0000 | 40,175,926 | 2.76% | 0.04% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Common Stock | 105000 | $33.60 | 725,348.0000 | 40,175,926 | 16.93% | 0.26% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Common Stock | 32193 | $5.10 | 757,541.0000 | 40,175,926 | 4.44% | 0.08% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Common Stock | 62291 | $2.41 | 819,832.0000 | 40,175,926 | 8.22% | 0.16% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Common Stock | 281053 | $5.25 | 1,100,885.0000 | 40,175,926 | 34.28% | 0.70% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 106471 | $65.81 | 994,414.0000 | 40,175,926 | 9.67% | 0.27% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 209689 | $66.33 | 784,725.0000 | 40,175,926 | 21.09% | 0.52% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 8423 | $67.37 | 776,302.0000 | 40,175,926 | 1.07% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 199226 | $69.30 | 577,076.0000 | 40,175,926 | 25.66% | 0.50% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 26606 | $0.00 | 60.0000 | 40,175,926 | 99.77% | 0.07% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 16666 | $0.00 | 0.0000 | 40,175,926 | 100.00% | 0.04% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 105000 | $0.00 | 35,000.0000 | 40,175,926 | 75.00% | 0.26% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 32193 | $0.00 | 8,473.0000 | 40,175,926 | 79.16% | 0.08% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 62291 | $0.00 | 52,709.0000 | 40,175,926 | 54.17% | 0.16% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 281053 | $0.00 | 200,753.0000 | 40,175,926 | 58.33% | 0.70% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 55234 | $68.79 | 617,861.0000 | 40,175,926 | 8.21% | 0.14% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3291 | $70.73 | 582,590.0000 | 40,175,926 | 0.56% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4782 | $71.74 | 577,808.0000 | 40,175,926 | 0.82% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 732 | $72.64 | 577,076.0000 | 40,175,926 | 0.13% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 14183 | $65.97 | 738,179.0000 | 40,175,926 | 1.89% | 0.04% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 23095 | $66.79 | 715,084.0000 | 40,175,926 | 3.13% | 0.06% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 41989 | $67.70 | 673,095.0000 | 40,175,926 | 5.87% | 0.10% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 31980 | $69.84 | 585,881.0000 | 40,175,926 | 5.18% | 0.08% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | A | Common Stock | 53900 | $0.00 | 752,362.0000 | 40,175,926 | 7.72% | 0.13% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | A | Employee stock option (right to buy) | 115600 | $0.00 | 115,600.0000 | 40,175,926 | 9999.99% | 0.29% |
| Jan. 3, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10154 | $46.18 | 698,462.0000 | 40,175,926 | 1.43% | 0.03% |
| Jan. 2, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10077 | $45.37 | 709,476.0000 | 40,175,926 | 1.40% | 0.03% |
| Jan. 2, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 860 | $45.92 | 708,616.0000 | 40,175,926 | 0.12% | 0.00% |
| Oct. 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2220 | $50.25 | 719,553.0000 | 41,879,025 | 0.31% | 0.01% |
| Oct. 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 19413 | $49.34 | 721,773.0000 | 41,879,025 | 2.62% | 0.05% |
| Aug. 29, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 47551 | $47.16 | 752,026.0000 | 16,492,132 | 5.95% | 0.29% |
| Aug. 29, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10840 | $47.83 | 741,186.0000 | 16,492,132 | 1.44% | 0.07% |
| Aug. 28, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 30262 | $47.19 | 825,928.0000 | 16,492,132 | 3.53% | 0.18% |
| Aug. 28, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 26351 | $48.03 | 799,577.0000 | 16,492,132 | 3.19% | 0.16% |
| Aug. 5, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 32789 | $45.48 | 950,745.0000 | 16,492,132 | 3.33% | 0.20% |
| Aug. 5, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 25424 | $46.14 | 925,321.0000 | 16,492,132 | 2.67% | 0.15% |
| Aug. 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 6789 | $43.64 | 918,532.0000 | 16,492,132 | 0.73% | 0.04% |
| Aug. 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 22937 | $45.25 | 895,595.0000 | 16,492,132 | 2.50% | 0.14% |
| Aug. 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 39405 | $45.89 | 856,190.0000 | 16,492,132 | 4.40% | 0.24% |
| July 17, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | A | Common Stock | 850000 | $0.00 | 983,534.0000 | 16,492,132 | 636.54% | 5.15% |
| July 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 15058 | $41.63 | 133,534.0000 | 16,492,132 | 10.13% | 0.09% |
| July 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4198 | $41.22 | 148,592.0000 | 16,492,132 | 2.75% | 0.03% |
| April 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7597 | $41.67 | 152,790.0000 | 16,492,132 | 4.74% | 0.05% |
| April 1, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 11383 | $41.12 | 160,387.0000 | 16,492,132 | 6.63% | 0.07% |
| Jan. 25, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2527 | $48.30 | 171,770.0000 | 16,492,132 | 1.45% | 0.02% |
| Jan. 4, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Common Stock | 150000 | $0.00 | 174,297.0000 | 16,492,132 | 617.36% | 0.91% |
| Jan. 4, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 16,492,132 | 9999.99% | 0.61% |
| Oct. 20, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | M | Common Stock | 2143 | $1.75 | 195,426.0000 | 8,397,088 | 1.11% | 0.03% |
| Oct. 20, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | M | Common Stock | 3500 | $2.50 | 198,926.0000 | 8,397,088 | 1.79% | 0.04% |
| Oct. 20, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | M | Warrants (right to buy) | 4000 | $0.00 | 0.0000 | 8,397,088 | 100.00% | 0.05% |
| Oct. 20, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | M | Warrants (right to buy) | 2143 | $0.44 | 0.0000 | 8,397,088 | 100.00% | 0.03% |
| Oct. 20, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | M | Warrants (right to buy) | 3500 | $0.44 | 0.0000 | 8,397,088 | 100.00% | 0.04% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 35272 | $36.00 | 31,228.0000 | 8,397,088 | 53.04% | 0.42% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 6931 | $37.01 | 24,297.0000 | 8,397,088 | 22.19% | 0.08% |
| Oct. 20, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | M | Common Stock | 4000 | $4.50 | 193,283.0000 | 8,397,088 | 2.11% | 0.05% |
| Dec. 11, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 51205 | $35.26 | 66,500.0000 | 8,397,088 | 43.50% | 0.61% |
| Nov. 30, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 27716 | $28.65 | 108,062.0000 | 8,397,088 | 20.41% | 0.33% |
| Nov. 29, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 13510 | $28.26 | 135,778.0000 | 8,397,088 | 9.05% | 0.16% |
| Nov. 28, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 4458 | $27.59 | 163,605.0000 | 8,397,088 | 2.65% | 0.05% |
| Nov. 28, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 21220 | $27.03 | 168,063.0000 | 8,397,088 | 11.21% | 0.25% |
| Nov. 29, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | S | Common Stock | 14317 | $27.43 | 149,288.0000 | 8,397,088 | 8.75% | 0.17% |
| May 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Common Stock | 160602 | $0.00 | 189,283.0000 | 8,397,088 | 559.96% | 1.91% |
| May 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Employee stock option (right to buy) | 481806 | $0.00 | 481,806.0000 | 8,397,088 | 9999.99% | 5.74% |
| May 8, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Warrants (right to buy) | 2143 | $0.44 | 2,143.0000 | 8,397,088 | 9999.99% | 0.03% |
| May 8, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Warrants (right to buy) | 3500 | $0.44 | 3,500.0000 | 8,397,088 | 9999.99% | 0.04% |
| Jan. 25, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Anish Bhatnagar | Chief Executive Officer | A | Employee stock option (right to buy) | 115000 | $0.00 | 115,000.0000 | 8,397,088 | 9999.99% | 1.37% |